CCL2 and non-small cell lung carcinoma: NSCLC-derived EVs stimulated MCs to release several mediators, such as TNF-α and monocyte chemoattractant protein 1 (MCP-1)/chemokine (C-C motif) ligand 2 (CCL2), as well as enhancing both their chemotactic and chemokinetic activity [78].